News for Legend Biotech Corporation (LEGN)

U.S. stocks were higher, with the Dow Jones index gaining around 500 points on Friday. Shares of Quanex Building Products Corporation NX rose sharply during Fr...

**media[634784]**

SOMERSET, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation ( LEGN) (Legend Biotech), a global leader in cell therapy, will host a live webcas

On May 14, 2025, Truist Securities maintained its 'Buy' rating on Legend Biotech (LEGN) but revised its price target. The new price target has been set at $71.0

Stock futures are mixed, signaling a potential pause following Monday’s rally driven by optimism over a temporary U.S.-China trade deal. In corporate news, UnitedHealth Group shares plunged 10% after CEO Andrew Witty stepped down, with former CEO Stephen Hemsley stepping in. The company also suspended its outlook due to rising medical costs. Bitcoin has regained value above $103,800, aligning with Coinbase’s rise after inclusion into the S&P 500. In pre-market trading, S&P 500 futures were fla

Legend Biotech Corporation (NASDAQ:LEGN) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ETCompany ParticipantsCaroline Paul - Associate Director,...

The following slide deck was published by Legend Biotech Corporation in conjunction with their 2025 Q1 earnings call.

Legend Biotech (LEGN) to announce Q1 earnings on May 13. Analysts predict -$0.25 EPS & $193.88M revenue.

Legend Biotech faces a 60% stock drop amid safety, supply issues, and competition for its CAR-T therapy, Carvykti. See here for an analysis of LEGN stock.

SOMERSET, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation ( LEGN) (Legend Biotech), a global leader in cell therapy, will host a conferenc

We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at where Legend Biotech Corporation (NASDAQ:LEGN) stands against other takeover rumor stocks hedge funds are buying. Hedge funds tend to pile up on a stock that gains or is expected to gain […]

Editor's Note: This headline has been corrected to reflect that the stock moves occurred on Tuesday U.S. stocks were higher, with the Dow Jones index gaining a...

The major U.S. stock indexes are showing solid gains in midday trading on Tuesday, April 15, 2025, as investors continue to process the latest developments

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday. Shares of Netflix, Inc. NFLX rose sharply during Tuesday's session after...

Transaction Overview On March 6, 2025, RA Capital Management, L.P. made a significant addition to its portfolio by acquiring 1,605,725 shares of Janux Therapeut

Legend Biotech Corporation (NASDAQ:LEGN) Q4 2024 Earnings Conference Call March 11, 2025 8:00 AM ETCompany ParticipantsCaroline Paul - Associate Director,...

Although the revenue and EPS for Legend Biotech (LEGN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

CARVYKTI® net trade sales of approximately $334 million and $963 million for the fourth quarter and full year 2024, respectivelyOver 5,000 patients treated to

The stock market on Tuesday, March 11, 2025, shows signs of stabilizing after a tumultuous start to the week. Investors are closely watching major market